ArticleFrontiers in pharmacology2022

Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension.

Zeyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.